Loading...
XLON
ANIC
Market cap92mUSD
Dec 04, Last price  
6.90GBP
1D
-2.82%
1Q
-5.22%
Jan 2017
28.37%
IPO
-22.47%
Name

Agronomics Ltd

Chart & Performance

D1W1MN
XLON:ANIC chart
P/E
3.11
P/S
2.34
EPS
0.02
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-6.69%
Revenues
30m
+6,645.82%
510,515588,9662,099,040-190,775-317,84262,17820,818-11,5561,277,366260,104440,32229,703,324
Net income
22m
+275.22%
425,208415,1581,381,475-601,646-534,369-37,030-211,406-276,897611,731-7,703,7365,962,74922,373,676
CFO
-24m
L-42.19%
-48,998-103,376-363,744-804,241-189,535-261,110-196,460-181,309-666,383-12,169,154-42,207,998-24,402,239

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Agronomics Limited is a principal investment firm specializing in investments in funds, equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, nascent industry of modern foods, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.
IPO date
Sep 15, 2011
Employees
0
Domiciled in
IM
Incorporated in
IM

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT